… However, Curtius and Al Bakir propose that mathematical models of carcinogenesis can be
used to evaluate and predict the efficacy of screening strategies using multiscale approaches…

Optimizing the management of colorectal cancer (CRC) risk in IBD requires a fundamental
understanding of the evolutionary process underpinning tumorigenesis. In IBD, clonal …

Background and Aims Alterations in body composition are common in inflammatory bowel
disease [IBD] and have been associated with differences in patient outcomes. We sought to …

Objective Ulcerative colitis (UC) is a dynamic disease with its severity continuously changing
over time. We hypothesised that the risk of colorectal neoplasia (CRN) in UC closely …

Objective IBD confers an increased lifetime risk of developing colorectal cancer (CRC), and
colitis-associated CRC (CA-CRC) is molecularly distinct from sporadic CRC (S-CRC). Here …

Clinical archives of patient material near-exclusively consist of formalin-fixed and paraffin-embedded
(FFPE) blocks. The ability to precisely characterise mutational signatures from FFPE…

Background and study aims: EndoClot is a novel topical hemostatic powder approved for use
in non-variceal upper gastrointestinal bleeding. This study examines its impact as rescue …

Patients with inflammatory bowel disease have an increased risk of developing colorectal
cancer, and this risk is related to disease duration, extent, and cumulative inflammation burden…

Objective Patients with ulcerative colitis (UC) diagnosed with low-grade dysplasia (LGD) have
increased risk of developing advanced neoplasia (AN: high-grade dysplasia or colorectal …

Faecal calprotectin is a sensitive marker of intestinal inflammation and may be elevated in
conditions other than inflammatory bowel disease, such as diverticulitis and infectious …